BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3954808)

  • 21. [Symptomatologic value of telangiectasia in the course of scleroderma].
    Colomb D; Latarche M; David D
    Angeiologie; 1971; 23(2):91-2. PubMed ID: 5566593
    [No Abstract]   [Full Text] [Related]  

  • 22. [Early diagnosis of progressive systemic sclerosis: the role of oro-facial phenomena].
    Scardina GA; Mazzullo M; Messina P
    Minerva Stomatol; 2002; 51(7-8):311-7. PubMed ID: 12434126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telangiectasias: Small lesions referring to serious disorders.
    Schieving JH; Schoenaker MHD; Weemaes CM; van Deuren M; van der Flier M; Seyger MM; Willemsen MAAP
    Eur J Paediatr Neurol; 2017 Nov; 21(6):807-815. PubMed ID: 28803159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Myositis disclosing systemic scleroderma].
    Leys D; Hatron PY; Parent M; Pasquier F; Krivosic I; Petit H
    Rev Neurol (Paris); 1984; 140(11):670-2. PubMed ID: 6505497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cutaneomucous aspects of scleroderma].
    Texier L; Rommel A
    Ann Med Interne (Paris); 1984; 135(8):580-3. PubMed ID: 6529052
    [No Abstract]   [Full Text] [Related]  

  • 26. Skin Telangiectasia and the Identification of a Subset of Systemic Sclerosis Patients With Severe Vascular Disease.
    Hurabielle C; Avouac J; Lepri G; de Risi T; Kahan A; Allanore Y
    Arthritis Care Res (Hoboken); 2016 Jul; 68(7):1021-7. PubMed ID: 26474084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Calcinosis, Raynaud's disease, slcerodactylia and telangiectasias in progressive systemic sclerosis. Statistic analysis of contingencies].
    Mintz G
    Gac Med Mex; 1974 Jun; 107(6):525-36. PubMed ID: 4448356
    [No Abstract]   [Full Text] [Related]  

  • 28. The relationship between nailfold capillaroscopic assessment and telangiectasia score with severity of peripheral vascular involvement in systemic sclerosis.
    Yalcinkaya Y; Pehlivan O; Omma A; Alpay N; Erer B; Kamali S; Ocal L; Inanc M
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S92-7. PubMed ID: 25797836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Articular manifestations in systemic progressive sclerosis].
    Messina OD; Maldonado Cocco JA; Nasswetter GG; García Morteo OM
    Rev Clin Esp; 1985 Apr; 176(7):354-5. PubMed ID: 4011982
    [No Abstract]   [Full Text] [Related]  

  • 30. Vesical telangiectasias as a cause of macroscopic hematuria in systemic sclerosis.
    De Luca A; Terrone C; Tirri E; Rossetti SR; Valentini G
    Clin Exp Rheumatol; 2001; 19(1):93-4. PubMed ID: 11247335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the oral manifestations of systemic sclerosis.
    Nagy G; Kovács J; Zeher M; Czirják L
    Oral Surg Oral Med Oral Pathol; 1994 Feb; 77(2):141-6. PubMed ID: 8139831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis.
    Lovy M; MacCarter D; Steigerwald JC
    Arthritis Rheum; 1985 May; 28(5):496-501. PubMed ID: 4004959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and laboratory features of Japanese patients with scleroderma and telangiectasia.
    Ashida R; Ihn H; Mimura Y; Jinnin M; Asano Y; Kubo M; Tamaki K
    Clin Exp Dermatol; 2009 Oct; 34(7):781-3. PubMed ID: 19508567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis.
    Hudson M; Taillefer S; Steele R; Dunne J; Johnson SR; Jones N; Mathieu JP; Baron M
    Clin Exp Rheumatol; 2007; 25(5):754-7. PubMed ID: 18078627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Test and teach. Number thirty-five. Diagnosis: progressive systemic sclerosis involving the colon.
    Rocca JM; Rowland R; Hunter R
    Pathology; 1982 Oct; 14(4):347-8, 485-6. PubMed ID: 7155630
    [No Abstract]   [Full Text] [Related]  

  • 36. Ophthalmic manifestations of progressive systemic sclerosis.
    Horan EC
    Br J Ophthalmol; 1969 Jun; 53(6):388-92. PubMed ID: 5794954
    [No Abstract]   [Full Text] [Related]  

  • 37. Anaemia due to blood loss from the telangiectases of scleroderma.
    Holt JM; Wright R
    Br Med J; 1967 Aug; 3(5564):537-8. PubMed ID: 5298612
    [No Abstract]   [Full Text] [Related]  

  • 38. Small bowel telangiectasia in scleroderma.
    Vautier G; McDermott E; Carty JE; Scott BB
    Ann Rheum Dis; 1995 Jan; 54(1):78. PubMed ID: 7880130
    [No Abstract]   [Full Text] [Related]  

  • 39. [Systemic sclerosis in 2017].
    Soukup T; Veleta T
    Vnitr Lek; 2018; 64(2):146-154. PubMed ID: 29595279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scleroderma with diverticulosis and colonic obstruction.
    Compton R
    Am J Surg; 1969 Oct; 118(4):602-6. PubMed ID: 5821702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.